James T.. Boyle Jr's Net Worth

$21.9 Million

Estimate Recalculated Nov 7, 2024 11:34AM EST

Who is James T.. Boyle Jr?

James T.. Boyle Jr has an estimated net worth of $21.9 Million. This is based on reported shares across multiple companies, which include LABORATORY CORP OF AMERICA HOLDINGS, and ORCHID CELLMARK INC.

SEC CIK

James T.. Boyle Jr's CIK is 0001454748

Past Insider Trading and Trends

2013 was James T.. Boyle Jr's most active year for acquiring shares with 9 total transactions. James T.. Boyle Jr's most active month to acquire stocks was the month of January. 2015 was James T.. Boyle Jr's most active year for disposing of shares, totalling 20 transactions. James T.. Boyle Jr's most active month to dispose stocks was the month of January. 2013 saw James T.. Boyle Jr paying a total of $9,910,498.26 for 178,219 shares, this is the most they've acquired in one year. In 2013 James T.. Boyle Jr cashed out on 312,214 shares for a total of $15,921,867.55, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

LABORATORY CORP OF AMERICA HOLDINGS (LH) Snapshot price: $223.91

EVP,CEO LabCorp Diagnostics

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$117.31
-$4,074,929.01
23.45K
Scheduled
Mar 30 - Mar 31
Form 4
—
0
$115.40
-$341,126.13
23.45K
Scheduled
Mar 11 - Mar 14
Form 4
-14.74%
-4.05K
$103.02
-$417,746.10
23.45K
Scheduled
Feb 16
Form 4
+17.29%
4.05K
$102.07
-$630,102.36
27.51K
Scheduled
Feb 11 - Feb 12
Form 4
—
0
—
—
0
Feb 9
Form 4
-5.61%
-1.39K
$126.56
-$176,424.76
23.45K
Scheduled
Apr 23
Form 4
+5.94%
1.39K
$127.28
-$161,900.16
24.85K
Mar 30
Form 4
—
0
—
—
0
Mar 11
Form 4
-9.17%
-2.37K
$123.54
-$292,411.87
23.45K
Scheduled
Mar 2 - Mar 3
Form 4
-9.51%
-2.71K
$116.72
-$1,036,954.80
25.82K
Scheduled
Feb 12 - Feb 13
Form 4
+10.51%
2.71K
$116.73
-$156,651.66
28.54K
Feb 11
Form 4
—
0
$93.93
-$700,204.00
25.82K
Jun 9
Form 4
—
0
$98.13
-$473,458.04
25.82K
Scheduled
Mar 27 - Mar 28
Form 4
-5.77%
-1.58K
$93.06
-$147,220.92
25.82K
Scheduled
Mar 3
Form 4
-2.78%
-785.00
$93.54
-$73,428.90
27.4K
Feb 28
Form 4
—
0
$90.52
-$558,410.75
28.19K
Scheduled
Feb 12 - Feb 13
Form 4
—
0
—
—
0
Feb 11
Form 4
-6.00%
-1.80K
$91.22
-$164,189.20
28.19K
Scheduled
Feb 10 - Feb 11
Form 4
—
0
$89.79
-$596,028.00
29.99K
Scheduled
Oct 17
Form 4
—
0
$84.89
-$1,860,188.00
29.99K
Jun 7
Form 4
—
0
—
—
0
Jun 3
Form 4
-21.42%
-8.17K
$76.47
-$2,873,604.61
29.99K
May 10
Form 4
+18.62%
5.99K
$90.20
-$494,656.80
38.16K
Mar 28
Form 4
-2.40%
-790.00
$88.60
-$69,994.00
32.17K
Feb 28
Form 4
—
0
—
—
0
Feb 12
Form 4
-3.79%
-1.30K
$90.06
-$116,897.88
32.96K
Feb 11
Form 4
—
0
—
—
0
May 24
Form 4
+49.03%
11.27K
$91.90
-$764,148.50
34.26K
Mar 26
Form 4
+44.69%
7.1K
—
—
22.99K
Feb 28
Form 4
-9.84%
-1.73K
$91.55
-$158,749.46
15.89K
Feb 9 - Feb 10
Form 4
+6.38%
1.06K
$91.57
-$71,424.60
17.62K
Mar 30
Form 4
-0.84%
-141.00
$87.73
-$12,369.93
16.57K
Feb 14
Form 4
+34.11%
4.25K
$89.52
-$103,039.08
16.71K
Feb 9 - Feb 10
Form 4
-1.88%
-239.00
$73.97
-$17,678.83
12.46K
Feb 22
Form 4
-1.10%
-141.00
$72.43
-$10,212.63
12.7K
Feb 16
Form 4
+80.27%
5.72K
$70.97
-$34,349.48
12.84K
Feb 9 - Feb 10
Form 4
-6.71%
-512.00
$62.33
-$31,911.91
7.12K
Feb 20 - Feb 23
Form 4
-2.15%
-168.00
$62.42
-$10,486.56
7.63K
Feb 13
Form 4
+122.82%
4.3K
—
—
7.8K
Feb 11
Form 3
—
0
—
—
0
No matching records found

ORCHID CELLMARK INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found